2019 ACR/AF 幼年特发性关节炎治疗指南:非系统性多关节炎、骶髂关节炎和附着点炎的治疗方法
推荐涵盖非甾体抗炎药、改善病情抗风湿药、生物制剂、关节腔和口服糖皮质激素及物理/作业治疗,强调良好疾病控制和升级治疗以达到低疾病活动度。
要点
- 90% 推荐的支持证据质量评为极低或低。
- 推荐良好疾病控制,并通过治疗升级达到低疾病活动度。
核心结论
- 该指南为临床医生、照护者和患者提供 JIA 非系统性多关节炎、骶髂关节炎和附着点炎的治疗决策方向。
- 推荐应通过共享决策过程使用,考虑患者的价值观、偏好和合并症,且不应用于限制或拒绝治疗可及性。
研究设计与样本
- 指南制定小组开发并精炼 PICO 问题,进行系统评价汇总治疗获益与危害证据。
- 采用 GRADE 方法评级证据质量,投票小组通过共识过程生成最终推荐并评定强度。
- 家长和患者小组采用类似共识方法提供患者/照护者对关键问题的偏好。
主要发现
- 90% 推荐的支持证据质量评为极低或低。
- 推荐涉及非甾体抗炎药、改善病情抗风湿药、生物制剂、关节腔和口服糖皮质激素的使用。
- 还提供了物理治疗和作业治疗的使用推荐。
- 多关节炎推荐涵盖一般用药、初始和后续治疗及辅助治疗;骶髂关节炎和附着点炎推荐主要针对初始治疗和辅助治疗。
关键数值与推荐
- 推荐良好疾病控制,并通过治疗升级达到低疾病活动度。
临床怎么用
- 临床医生可依据推荐选择非甾体抗炎药、改善病情抗风湿药、生物制剂、糖皮质激素及物理/作业治疗。
- 对多关节炎患儿应追求良好疾病控制,必要时升级治疗以达到低疾病活动度。
- 治疗决策应采用共享决策,考虑患者价值观、偏好和合并症。
局限性
- 90% 推荐的支持证据质量评为极低或低。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To develop treatment recommendations for children with juvenile idiopathic arthritis manifesting as non-systemic polyarthritis, sacroiliitis, or enthesitis. METHODS: The Patient/Population, Intervention, Comparison, and Outcomes (PICO) questions were developed and refined by members of the guideline development teams. A systematic review was conducted to compile evidence for the benefits and harms associated with treatments for these conditions. GRADE (Grading of Recommendations Assessment, Development and Evaluation) methodology was used to rate the quality of evidence. A group consensus process was conducted among the Voting Panel to generate the final recommendations and grade their strength. A Parent and Patient Panel used a similar consensus approach to provide patient/caregiver preferences for key questions. RESULTS: Thirty-nine recommendations were developed (8 strong and 31 conditional). The quality of supporting evidence was very low or low for 90% of the recommendations. Recommendations are provided for the use of nonsteroidal antiinflammatory drugs, disease-modifying antirheumatic drugs, biologics, and intraarticular and oral glucocorticoids. Recommendations for the use of physical and occupational therapy are also provided. Specific recommendations for polyarthritis address general medication use, initial and subsequent treatment, and adjunctive therapies. Good disease control, with therapeutic escalation to achieve low disease activity, was recommended. The sacroiliitis and enthesitis recommendations primarily address initial therapy and adjunctive therapies. CONCLUSION: This guideline provides direction for clinicians, caregivers, and patients making treatment decisions. Clinicians, caregivers, and patients should use a shared decision-making process that accounts for patients' values, preferences, and comorbidities. These recommendations should not be used to limit or deny access to therapies.
引用
- Ringold S, Angeles-Han ST, Beukelman T, et al. 2019 American College of Rheumatology/Arthritis Foundation Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Non-Systemic Polyarthritis, Sacroiliitis, and Enthesitis. Arthritis Care Res (Hoboken). 2019. PMID: 31021516. doi:10.1002/acr.23870
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。